-
Has anyone tried Rituxan (Rituximab) for LEMS?
Rituxan (rituximab) is a medication used to treat various autoimmune conditions, including certain cancers, rheumatoid arthritis, and even some cases of myasthenia gravis. Some doctors are now exploring its use for Lambert-Eaton Myasthenic Syndrome (LEMS), especially in patients who don’t respond well to first-line treatments like Firdapse (amifampridine), Mestinon, IVIG, or plasma exchange.
Because Rituxan targets B-cells in the immune system, it may help reduce the autoimmune activity thought to be involved in LEMS. But it’s still considered off-label and isn’t widely used for LEMS yet, so information is limited—and patient experiences can be incredibly valuable.
Why This Matters:
Rituxan may be an option for people with treatment-resistant or more aggressive LEMS. Its immune-modulating effects might reduce the production of antibodies that block calcium channels at the neuromuscular junction.Understanding risks vs. benefits is key—especially when balancing immune suppression with quality of life.
Note:
Rituxan is a powerful drug that suppresses part of your immune system, so infection risk and long-term monitoring are important topics to discuss with your care team. It’s not FDA-approved for LEMS, and insurance coverage may vary.Have you used Rituxan or are you considering it? Share your story, questions, or advice. Your insight might help someone else facing a tough treatment decision.
Log in to reply.